Clin2
NCT07886606Possibly a fitRecruiting

CBD for opioid use disorder and chronic pain

Chronic PainOpioid Use Disorder

Part of Mental health, Pain clinical trials.

This study tests whether a CBD (cannabidiol) supplement, when taken along with your usual buprenorphine treatment, can help reduce chronic pain and improve your overall response to treatment for opioid use disorder. You would take the CBD for about 12 weeks and participate in study visits that check your progress.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
34 people
Ages
18 years to 70 years
Study type
Interventional

Who can take part

  • You are between 18 and 70 years old.
  • You have been diagnosed with opioid use disorder and are taking buprenorphine (at a stable dose) for at least 4 weeks.
  • You have had chronic pain (not from cancer) for at least 6 months.
  • You are not currently using THC or CBD products and are willing to stop using them for the study.
  • You are not taking certain medications like benzodiazepines, other prescription opioids, or blood thinners regularly.
  • You weigh at least 60 kg (about 132 pounds) and do not have allergies to sesame seed oil, Raynaud's phenomenon, or high blood pressure.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06544291Recruiting· Phase 2
THC and CBD for pain and opioid use disorder

This study tests whether a combination of THC and CBD can help people who have both opioid use disorder and chronic low back pain. You would need to be on a stable dose of methadone and have used cannabis at least once in your life.

New Haven, Connecticut
NCT07148206Not yet recruiting· Phase 3
Cannabis-like medicines for withdrawal symptoms when starting buprenorphine

This trial tests whether two cannabis-like medicines, dronabinol and Epidiolex, can help reduce withdrawal symptoms and other discomforts people may feel when they first start taking buprenorphine for opioid use disorder. If you've recently started buprenorphine and still have symptoms, this study might offer extra relief.

The Bronx, New York
NCT05985850Recruiting· Phase 2
Can cannabis help with opioid addiction treatment?

This trial tests if adding a specific cannabis product to standard methadone treatment helps people with opioid use disorder. It's for adults over 25 who recently started methadone and have used cannabis before.

Vancouver, British Columbia
NCT06574009Recruiting· Phase 4
Better options for chronic cancer pain in veterans

This study tests if switching from long-term opioid painkillers to buprenorphine (a different type of pain medication) can provide better pain relief for veterans who have had cancer but are currently cancer-free. It aims to find a safer and more effective way to manage chronic pain.

Indianapolis, Indiana
NCT06454669Recruiting· Phase 2
Dronabinol added to opioids for chronic low back pain

This trial tests whether adding dronabinol (a prescription medication derived from cannabis) to your current opioid pain treatment can help reduce chronic low back pain more effectively. It is for people who have had persistent low back pain for at least 3 months and are already on a stable opioid regimen.

Houston, Texas
NCT07783295Not yet recruiting· Phase 2
Cannabis extract for chronic pain and bone health in women

This study tests whether a full-spectrum cannabis extract (a whole-plant product containing many natural compounds) can help relieve chronic pain and improve markers of bone health in women. If you join, you'll take the extract and your pain and bone health will be monitored.

São Paulo, São Paulo

Hear when a new Chronic pain trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.